The therapy is expected to block abnormal blood vessel growth, limit vascular leakage, and reduce retina damage. The Food and Drug Administration (FDA) has granted Fast Track designation to SAR402663 ...

Nov. 10 -- MONDAY, Nov. 9 (HealthDay News) -- Cataract surgery doesn't appear to speed the progression of age-related macular degeneration (AMD), according to a new study that challenges the belief ...

Please provide your email address to receive an email when new articles are posted on . Khanani delved into tyrosine kinase inhibitors, including the SOL-1 and SOL-R trials evaluating OTX-TKI ...

The risk for neovascular age-related macular degeneration (nAMD) seems not to be increased following cataract surgery, according to a research letter published online Feb. 5 in JAMA Ophthalmology.

A widely used diabetes and weight-loss medicine is now under closer review after a large new study raised concerns about its ...

SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular AMD across all GA lesion types at 1 ...

The evidence evaluating the effect of cataract surgery on the chances people with dry age-related macular degeneration (AMD) will convert to the more severe wet form of the condition has been uneven ...

Patients with neovascular age‑related macular degeneration (AMD) whose retinal fluid cleared within 12 weeks of starting faricimab were more likely to have longer intervals between injections later in ...

Please provide your email address to receive an email when new articles are posted on . Patients with diabetes taking GLP-1s had a twofold higher risk for wet AMD development in unadjusted and ...